Yahoo
Paris - Delayed Quote EUR

GenSight Biologics S.A. (SIGHT.PA)

0.0731 -0.0041 (-5.31%)
At close: 5:35:26 PM GMT+1
View in AlphaSpace Currency in EUR All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Operating Cash Flow
-8,266
-9,170
-12,937
-24,663
-33,753
Investing Cash Flow
165
180
17
209
172
Financing Cash Flow
9,620
8,937
13,542
15,859
95
End Cash Position
1,789
2,415
2,464
2,134
10,610
Capital Expenditure
-1
-4
-1
-10
-252
Issuance of Capital Stock
10,871
10,400
16,742
4,017
38
Issuance of Debt
0
0
0
14,182
10,800
Repayment of Debt
-497
-497
-2,153
-1,081
-7,822
Repurchase of Capital Stock
-27
--
-27
-99
-193
Free Cash Flow
-8,336
-9,174
-12,938
-24,673
-34,005
12/31/2022 - 7/13/2016

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: